Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 15,307.20 -80.41 -0.52%
S&P 500 1,655.35 -13.81 -0.83%
Nasdaq 3,463.30 -38.82 -1.11%
Ticker Volume Price Price Delta
STOXX 50 2,764.69 -70.32 -2.48%
FTSE 100 6,714.87 -125.40 -1.83%
DAX 8,309.68 -221.21 -2.59%
Ticker Volume Price Price Delta
Nikkei 14,484.00 -1,143.28 -7.32%
Hang Seng 22,669.70 -591.40 -2.54%
S&P/ASX 200 5,062.45 -102.92 -1.99%
  • Exchange: NASDAQ GS
  • Sector: Consumer, Non-cyclical
  • Industry: Pharmaceuticals
  • Sub-Industry: Medical-Generic Drugs

MYL:US

31.5500 USD 0.3200 1.02%

As of 20:10:00 ET on 05/22/2013.

Company Profile for Mylan Inc/PA (MYL)

Mylan Inc. is a global generic and specialty pharmaceuticals company. The Company operates an active pharmaceutical ingredient manufacturer and runs a specialty business focused on respiratory, allergy, and psychiatric therapies.

Contact Information

Mylan Inc/PA

1500 Corporate Drive
Suite 400
Canonsburg, PA 15317
United States
Phone: 1-724-514-1800

Key Executives for Mylan Inc/PA (MYL)

Robert J CouryChairmanRodney L PiattVice Chairman
Heather BreschChief Executive OfficerRajiv MalikPresident
Harry A Korman "Hal"Chief Operating OfficerAnthony Mauro "Tony" President:North America
John D SheehanExec VP/CFODaniel C Rizzo JrSenior VP/Chief Acctg Officer
Deborah M. AutorSenior VP:Global QualityKris KingVP:Global Investor Relations
Nina DevlinVP:Corp CommunicationsJoseph F HaggertySecretary

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil